Pomdoctor Limited (POM)

NASDAQ: POM · USD

$1.79

+0.40 (+28.8%)· Recorded snapshot

Market cap	5M
Revenue (ttm)	60.4M
Net income (ttm)	-54.5M
EPS (ttm)	-$30.1
Shares out	2.8M
Volume	39,832,363

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 60.4M
Net income (ttm): -54.5M
EPS (ttm): -$30.1
Market cap: 5M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All POM indicators

Market & fundamental data

Available fields

183

Groups with data

Currency

CNY

Showing 183 of 183 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001877971
Company name	Pomdoctor Limited
Country	China
Country code	US
CUSIP number	G7166T112
Earnings date	2026-11-10
Earnings time	amc
Employees	165
Employees change	9
Employees growth	5.77%
Enterprise value	$69.4M
Exchange	NASDAQ
Financial currency	CNY
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2015
Industry	Pharmaceutical Retailers
IPO date	2025-10-08
Is primary listing	Yes
Is SPAC	No
ISIN number	KYG7166T1123
Last 10-K release date	2026-05-14
Last earnings date	2026-05-14
Last refreshed	2026-10-28
Last stock split date	2026-10-21
Last stock split type	Reverse
Market cap	$5M
Market cap category	Nano-Cap
Next earnings date	2026-11-10
Options	No
Price	$1.79
Price currency	USD
Sector	Healthcare
SIC code	5900
Stock price date	2026-10-28
Symbol	POM
Website	https://www.7lk.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-1,679.97%
EV/Sales	1.13x
FCF / EV yield	-27.43%
FCF yield	-484.52%
P/S ratio	0.06x
Sector forward P/E	23.56x
Sector P/E	50.08x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-82.35%
EBITDA margin	-82.29%
Gross margin	12%
Operating margin	-82.35%
Pretax margin	-92.19%
Profit margin	-90.16%
Profit per employee	$-330,184
Revenue per employee	$366,204
ROA	-352.09%
ROA (5Y)	-44.13%
ROCE	250.75%
SBC / revenue	56.54%
Tax / revenue	0.02%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	2
Gross profit growth	-4.71%
Gross profit growth (Q)	3.83%
Gross profit growth 3Y	0.33%
Net income growth years	0
Revenue growth	11.88%
Revenue growth (Q)	6.04%
Revenue growth (QoQ)	-17.94%
Revenue growth 3Y	15.92%
Revenue growth years	2

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	$-214,274
Depreciation and amortization	$31,301
EBIT	$-49.8M
EBITDA	$-49.7M
EPS	$-30.07
FCF per share	$-6.73
Financing cash flow	$20M
Free cash flow	$-18.7M
Free cash flow minus SBC	$-53.5M
Gross profit	$7.2M
Income taxes	$9,938
Investing cash flow	$-170,568
Net borrowing	$-666,733
Net cash flow	$1M
Net income	$-54.5M
Operating cash flow minus SBC	$-53.3M
Operating income	$-49.8M
Revenue	$60.4M
Stock-based compensation	$34.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-61.19
Book value per share	$-29.87
Interest coverage	-26.96
Long-term assets	$145,777
Long-term liabilities	$54.1M
Net cash (debt)	$-64.4M
Net cash / market cap	-1,666.64%
Piotroski F-Score	2
Property, plant and equipment	$132,024
Shareholders' equity	$-74.5M
Tangible book value	$-69.3M
Tangible book value per share	$-29.87
Total assets	$11.2M
Total cash	$1.9M
Total debt	$66.3M
Total liabilities	$85.7M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	6.84
Current assets	$11.1M
Current liabilities	$31.6M
Current ratio	0.35
Inventory turnover	59.66
Net working capital	$-10.5M
Quick ratio	0.27
Working capital	$-20.2M
Working capital turnover	-0.45

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-143.37%
Dividend yield	0%
Shareholder yield	-143.37%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$2.26
1D price change	28.78%
1M price change	67.31%
1M total return	67.31%
1W price change	161.73%
1W total return	161.73%
1Y price change	-97.94%
1Y return CAGR	-97.95%
1Y total return	-97.94%
20-day SMA	$1.06
200-day SMA	$2.96
3M price change	141.3%
3M total return	141.3%
50-day SMA	$0.95
50-day SMA vs 200-day SMA	50under200
52-week high	$115.74
52-week high date	2025-11-06
52-week low	$0.43
52-week low date	2026-10-20
6M price change	-68%
6M total return	-68%
After-hours change	-2.23%
After-hours close	$1.79
After-hours price	$1.75
All-time high	$115.74
All-time high date	2025-11-06
All-time low	$0.43
All-time low date	2026-10-20
Average true range (ATR)	$0.50
Average volume	6.1M
Change from 52-week high	-98.45%
Change from 52-week low	313.4%
Change from all-time high	-98.5%
Change from all-time low	301.85%
Change from open	16.23%
Day's gap	10.79%
Dollar volume	$71.3M
High price	$2.94
Low price	$1.50
Monthly RSI	0
Open price	$1.54
Position in 52-week range	20.14%
Premarket change	10.07%
Premarket close	$1.39
Premarket price	$1.53
Premarket volume	532.6K
Previous close	$1.39
Price vs 150-day SMA	-23.01%
Price vs 20-day SMA	64.62%
Price vs 200-day SMA	-41.26%
Price vs 50-day SMA	83.47%
Relative volume	6.58
Return from IPO open	-98.28%
Return from IPO price	-65.25%
RSI	57.78
Sharpe ratio	0.56
Sortino ratio	1.44
Volume	39.8M
Weekly RSI	36.33
YTD price change	-67.22%
YTD total return	-67.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Shares change (QoQ)	77.63%
Shares change (YoY)	143.37%
Shares outstanding	2.8M
Short % of shares	0.04%
Short ratio	1.3 days

Other indicators

Additional ticker metrics that do not fit the primary research groupings.

Metric	Value
Page views	960

Deeper analysis on POM

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this POM report

Is a complete POM research report available?

No complete published report is available for Pomdoctor Limited (POM) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Pomdoctor Limited (POM)

Price

Financial snapshot

Fair-value bridge

Latest news · POM

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All POM indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on POM

Frequently asked questions